• 3830 Citations
  • 34 h-Index
1991 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimiliano Berretta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
HIV Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2018

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine

Rossi, P., Difrancia, R., Quagliariello, V., Savino, E., Tralongo, P., Randazzo, C. L. & Berretta, M., May 15 2018, In : Oncotarget. 9, 37, p. 24837-24856 20 p.

Research output: Contribution to journalReview article

Integrative Medicine

Cancer targeted therapy strategy: The pathologist’s perspectives

Alessandrini, L., Perin, T., Kadarè, S., Del Pup, L., Memeo, L., Steffan, A., Colarossi, L., Berretta, M., De Paoli, P. & Canzonieri, V., Jan 1 2018, In : Current Cancer Drug Targets. 18, 5, p. 410-420 11 p.

Research output: Contribution to journalReview article

Precision Medicine
Nucleic Acids

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis

Fiorica, F., Trovò, M., Ottaiano, A., Nasti, G., Carandina, I., Marzola, M., De Paoli, P. & Berretta, M., Feb 13 2018, In : Oncotarget. 9, 12, p. 10734-10744 11 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Disease-Free Survival
3 Citations (Scopus)
Non-Small Cell Lung Carcinoma
Cost-Benefit Analysis
Health Insurance
Health Care Costs
Disease-Free Survival

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies

Berretta, M., Micek, A., Lafranconi, A., Rossetti, S., Di Francia, R., De Paoli, P., Rossi, P. & Facchini, G., Apr 17 2018, In : Oncotarget. 9, 29, p. 20807-20815 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Cohort Studies
Prospective Studies